Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025".
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suraksha Diagnostic Limited has filed a press release dated February 5, 2026 with the stock exchange, sharing its unaudited standalone and consolidated financial results for the quarter ended December 31, 2025 (Q3 FY26) and the nine-month period ending the same date. This is a routine quarterly results disclosure required of listed companies. No specific revenue, profit, or growth numbers are included in this intimation, but the actual figures would be detailed in the press release itself. The filing signals timely compliance with exchange disclosure norms ahead of the earnings season.
This is a procedural disclosure and unlikely to move the stock on its own. Investors should look at the actual numbers in the press release to gauge revenue growth, margins, and diagnostics business trends, which will drive the next meaningful price reaction.